Commentary · 27 Dec 2024
Conference abstractPublished 2 Sep 2016
Guidelines for engineering of probiotics
InnovationWorks, Switzerland
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. Recent research has suggested that probiotics exert a wide range of effects through different mechanisms and sites of action, dependent on the host. Although the European Food Safety Agency has evaluated current probiotic strains insufficient characterized and clinical research ample for health claim approval, consumers (e.g., in the US) are interested in potential therapeutic and preventive health benefits. The Food and Agriculture Organization of the United Nations and the World Health Organization provide guidelines for probiotics: Proper identification to the level of strain of all probiotics in the product, with deposit of all strains in an international culture collection; Characterization of each strain for traits important to its safety and function; Validation of health benefits in human studies, including identification of the quantity of the microorganism required to provide the benefit and; Truthful and not misleading labeling of efficacy claims and content through the end of shelf life. Over the last years we have seen examples of genetically modified strains with adapted physiological properties compared to the parenteral strain and these provide a start for prosperous future developments. The genetic modifications can impact improved survival/retention in the gastrointestinal tract, cell cycle, cell wall, antibiotic resistance and biochemical/metabolic properties of the strains. The current guidelines that any strain of microorganism that would be assigned to a group would be freed from the need for further safety assessment is insufficient to guarantee any health impact in short and long term. It is therefore crucial that improved guidelines allow flexible developments to secure quality and safety, specifically when it concerns infants and premature infants or metabolically compromised individuals and when it concerns the possible long-term effects.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 28 Dec 2022
Impacts of Osseo Integration by Engineered Probiotics Biofilm
Commentary · 17 Nov 2022
Biocompatible Polymers as Promising Therapeutic Substrates for Engineered Probiotic Bacteria
Commentary · 5 Aug 2022
Advancements in Synthetic Biology and Engineering of Probiotics
Conference abstract · 14 Dec 2017
Enhancing animal welfare for good science through guidelines and regulations in Singapore
More from this journal
The newest in Journal of Biotechnology & Biomaterials.
Editorial · 30 May 2025
Biocatalytic Conversion of Agricultural Waste into Value-Added Chemicals Using Engineered Microbial Systems
Editorial · 30 May 2025
3D Bioprinting of Vascularized Tissue Constructs Using Bioink-Embedded Endothelial Cells
Editorial · 30 May 2025
Development of Flexible Bioelectronic Interfaces for Real-Time Neural Signal Monitoring
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biotechnology & Biomaterials
- SubjectBiochemistry & Biotechnology
- SubjectMaterials Science
- BylineArticles whose byline prints “Rob te Biesebeke”
